Hereditary hemochromatosis (HH) is an autosomal recessive disorder of excess 23 iron absorption. The most common form, HH1, is caused by loss of function variants in 24 HFE. HFE encodes a cell surface protein that binds to the Transferrin Receptor (TfR1), 25 reducing TfR1's affinity for the transferrin/iron complex and thereby limiting cellular 26 iron uptake. Two common missense alleles for HH1 have been identified, HFE C282Y 27
Introduction 45
Hereditary hemochromatosis (HH) is a genetic disorder in which the body absorbs 46 excess iron. 1 The excess iron can cause damage to the body's tissues, resulting in aStudent's two tailed t-tests were used for comparisons between groups. For confocal 114 microscopy, cells were stained as above, fixed with 4% paraformaldehyde, washed with 115 PBS+Hoechst, and imaged on an Olympus FV-1000 confocal microscope using identical 116 settings for each mutation. 117 118
Co-Immunoprecipitation 119
HeLa cells were chosen for coimmunoprecipitation experiments because wildtype HFE 120 trafficked best to the cell surface in HeLa cells ( Figure S1 ) and they had been previously 121 used for coimmunoprecipitation experiments.
9 HeLa cells were cotransfected using 122
Fugene 6 with wildtype or mutant HFE-GFP plasmids (see above) and a Transferrin 123
Receptor 1 expression plasmid pcDNA3.2/DEST/hTfR-HA, a gift from Robin Shaw 124 (Addgene plasmid #69610). A Pierce Classic Magnetic IP/Co-IP Kit (ThermoFisher 125 #88804) was used to harvest and coimmunoprecipitate the cells, following 126 manufacturer's instructions. Cells were precipitated with a rabbit anti-GFP antibody 127 (AbCam #ab290), then Western blots were performed using the anti-GFP antibody 128
(1:2500) or a mouse anti-TfR1 antibody (ThermoFisher #13-6800, 1:500) or a secondary 129 anti-rabbit HRP (Promega #W4011) and anti-mouse HRP Figure S1 ). To test 162 whether mutant HFE proteins were present in different abundances at the cell surface, we 163 examined the cellular localization of GFP-tagged HFE wildtype protein and HFE mutants 164 H63D, E168Q, C282Y, and the E168Q+H63D double mutant (hereafter referred to as 165 E168Q+H63D) (Figure 1 ). C282Y showed a dramatic trafficking defect (5% of wildtype 166 level, p=3.2e-5, two-tailed T test). E168Q had a mild but significant increase in surface 167 abundance (136% of wildtype level, p=0.01). H63D surprisingly had a higher abundance 168 than wildtype (722% of wildtype level, p=0.02). E168Q+H63D also had a large increase 169 in surface abundance (970% of wildtype level, p=0.02). Similar relative surface 170 abundance results were observed in the HepG2 liver cell line, albeit with lower overall 171 levels of surface trafficking (Figures 1, S1 ). Therefore, in contrast to C282Y, H63D and 172
H63D+E168Q have increased cell surface abundances. 173 174

HFE E168 is at the interface of the HFE-Transferrin Receptor interaction 175
We next examined the location of E168Q within the HFE protein. A crystal 176 structure of the HFE-TfR1 interaction has been solved, together with the HFE binding 177 partner B2M (Figure 2) . 15 That crystal structure revealed six residues of HFE that made 178 salt bridges with TfR1 (Table S1 ). Intriguingly, in the structure, one of these residues is 179 HFE E168, which is located at the HFE-TfR1 interface, and makes salt bridges with two 180
TfR1 residues (TfR1-R629 and TfR1-Q640). HFE E168Q is also predicted to make an 181 intramolecular salt bridge with HFE N108. 182
Because of HFE E168's location and contacts with TfR1, we hypothesized that 185 the HFE E168Q variant disrupts the binding between HFE and TfR1. To test this, we 186 performed coimmunoprecipitation experiments, precipitating HFE-GFP using an anti-187 GFP antibody and measuring coimmunoprecipitation of TfR1 (Figure 3 
Mechanism of HFE E168Q 224
A main mechanism of transmembrane proteins having loss of function is 225 misfolding and subsequent failure to traffic to the cell membrane. However, in this work, 226
we surprisingly observed that HFE E168Q+H63D had increased abundance at the cell 227 surface. Much of this surface abundance difference was due to H63D, although E168Q 228 alone had a mild but significant increase in surface abundance. We observed that HFE 229 E168 was at the interface of the HFE-TfR1 interaction and made multiple salt bridge 230 contacts with TfR1, suggesting that E168Q would disrupt the salt bridge contacts with 231 TfR1. Indeed, coimmunoprecipitation experiments showed a complete loss of binding of 232 E168Q and E168Q+H63D. Although it is difficult to predict the exact configuration of 233 the mutant glutamine in the crystal structure, the glutamine likely completely disrupts the 234 interaction between HFE-168 and TfR1-R629 and likely alters the contacts with TfR1-235 Q640. Two main alpha helices make contact with TfR1, termed α1 and α2.
15 HFE E168 236 is located in α2. Previous work showed that mutation to alanine of two residues in α1, 237 V100 and W103 (called V78 and W81 in the original paper), also abrogated the binding 238 between HFE and TfR1.
17 Therefore, we propose a model in which HFE E168Q is unable 239 to bind TfR1 and TfR1 therefore has an increased affinity for transferrin, causing iron 240 overload and HH1. 241 242
Improved prediction of HH risk 243
Our results suggest a template for improved prediction of HH risk. Our results 244 further suggest that genotyping for H63D and C282Y alone might not be sufficient to 245 determine HH1 risk. H63D is considered to be a low/variable penetrance HH1 allele, 5, 6 246 and E168Q presence may underlie some of the HH1 risk previously attributed to H63D 247 alone and explain some of its variable penetrance. 18 Other rare HFE variants in α1 and α2 248 or making salt bridge connections with TfR1 may also disrupt TfR1 binding and lead to 249 hemochromatosis. Integrated phenotyping methods like PheRS show promise to identify 250 risk variants and may also identify patients with underrecognized disease. However, 251 further functional studies are often necessary to validate these variants; 9/18 variants in 252 the initial PheRS paper were classified as variants of uncertain significance despite their 253 statistical association with disease. 10 In vitro functional studies such as the surface 254 abundance and coimmunoprecipitation studies in this paper can validate the genetic 255 results and result in reclassification of variants as benign or pathogenic. We anticipate 256 that these methods will be more broadly applied to other variants, genes, and diseases to 257 better predict disease risk.
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